Critical Limb Ischemia Treatment Market to Grow at an 8.03% CAGR from 2023 to 2031, reaching USD 3.49 billion: TMR Report
Increasing popularity of effective medications like beta-blockers, antiplatelet drugs, and statins is expected to drive critical limb ischemia treatment market growth.Wilmington, Delaware, United States, July 24, 2023 (GLOBE NEWSWIRE) -- The global critical limb ischemia treatment market is anticipated to grow at 8.03 % CAGR from 2023 to 2031. A market valuation of US$ 3.49 billion by 2031. The demand for critical limb ischemia therapeutics is expected to rise due to increasing prevalence of hyp
United States Nikhil Sawlani Asia Pacific Boston Scientific Corporation Transparency Market Research Inc Abbott Laboratories
Source: yahoo.com